Primary Job Title Co-Founder Primary Organization Alys Pharmaceuticals
Location Atlanta, Georgia, United States Regions Greater Atlanta Area, East Coast, Southern US Gender Male
LinkedIn View on LinkedIn
Mark Prausnitz is Regents’ Professor of Chemical and Biomedical Engineering, Love Family Professor of Chemical & Biomolecular Engineering, and Director of the Center for Drug Design, Development and Delivery at the Georgia Institute of Technology. His research interests focus on biophysical methods of drug delivery, which employ microfabricated
devices, microneedles, ultrasound, lasers, electric fields and other physical means to control the transport of drugs, proteins, genes and vaccines into and within the body.
Dr. Prausnitz earned a B.S. degree from Stanford University and a Ph.D. degree from the Massachusetts Institute of Technology, both in chemical engineering.
He worked for one year at Alza Corporation carrying out research on transdermal drug delivery systems and for one year at ORBIS International teaching biomedical engineering in developing country hospitals.
He has co-founded three start-up companies, most recently Clearside Biomedical. At Georgia Tech, Dr. Prausnitz teaches an introductory course on engineering calculations, as well as two advanced courses on pharmaceuticals and technical communication, both of which he developed. He also serves the broader scientific and business communities as a frequent consultant, advisory board member and expert witness. Dr. Prausnitz has published more than 160 research articles; given 150 invited lectures at conferences, universities and companies; filed 35 issued or pending patents; and supervised more than 30 doctoral theses.